TAKE THIS POLL |
|
|
- Gilead Sciences Chairman and CEO John C. Martin exercises options for 70,000 shares 16 May 2008 19:56 GMT
... Gilead Sciences Chairman and CEO John C. Martin exercises options for 70,000 shares Gilead Sciences Chairman ...
- Gilead Sciences CEO exercises options 16 May 2008 19:54 GMT
... NEW YORK — The chairman and chief executive of biopharmaceutical company Gilead Sciences Inc. exercised options for 70,000 shares of common stock, according to a Securities and ...
- Check who you could meet at the Travel Distribution Summit Europe. 15 May 2008 13:18 GMT
... Marketing Director Generator Hostels Managing Partner Genesys I T Manager Ghana Tours Travel Coordinator Gilead Sciences Europe Ltd Consultant Glebe MIR Services Director of Marketing Services Global Hotel Alliance Managing ...
- Gilead Sciences to Present at the 2008 Citi Investment... 15 May 2008 04:40 GMT
... time for any software download that may be necessary to listen to the webcast. Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of ...
- Most Effective Initial Therapy For HIV-1 Infection Identified 14 May 2008 23:50 GMT
... Laboratories, Abbott Park, Ill.; Tania George, Pharm.D., Bristol-Myers Squibb, Plainsboro, N.J.; James Rooney, M.D., Gilead Sciences, Foster City, Calif.; Barbara Brizz, M.S.H.Ed., B.S.N., Social & Scientific Systems, Inc., Silver Spring, ...
- Gilead Sciences to Present at the 2008 Citi Investment Research Global Healthcare Conference on Wednesday, 14 May 2008 23:07 GMT
... - Gilead Sciences, Inc. Susan Hubbard, Investor Relations, 650-522-5715 Gilead Sciences, Inc. (Nasdaq: GILD) today announced that ...
- Gilead Sciences to Present at the 2008 Citi Investment Research Global Healthcare Conference on Wednesday, May 21 14 May 2008 20:57 GMT
... time for any software download that may be necessary to listen to the webcast. Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of ...
- Genelabs Q1 loss more than doubles 14 May 2008 20:37 GMT
... Inc. which was partially offset by a decrease in revenue associated with collaboration with Gilead Sciences Inc. The company also recorded a gain of $1.2 million on the disposition of ...
- Bird flu pandemic seen needing multiple drugs 14 May 2008 19:48 GMT
... Tamiflu. But cases of resistance remain relatively rare. Tamiflu, which was originally developed by Gilead Sciences Inc, had sales of 1.9 billion Swiss francs ($1.8 billion) in 2007, making it ...
- WHO: Patents Won't Block Access To Avian Flu Medicines 14 May 2008 18:29 GMT
... have been infected of whom 64 have died, the WHO said. A spokesperson for Gilead Sciences, a US pharmaceutical company, said in an interview that the company developed the Tamiflu ...
- Genelabs Reports Results for the First Quarter of 2008 and Progress on Operational Priorities 14 May 2008 15:11 GMT
... which was partially offset by a decrease in revenue associated with our collaboration with Gilead Sciences, Inc. (Gilead). The increase in operating expenses in the comparable periods resulted primarily from ...
- Option Skews - Apple Inc, SanDisk Corp, Crocs Inc, JA Solar Holdings Co Ltd, MEMC Electronic Materials, Bunge Limited 14 May 2008 13:36 GMT
... Corp. (SINA), Sotheby's Holdings (BID), Diana Shipping Inc. (DSX), Alcoa (AA), SanDisk Corp. (SNDK), Gilead Sciences (GILD), Deere & (DE), Caterpillar (CAT), QUALCOMM Incorporated (QCOM), Valero Energy (VLO), JA Solar ...
- Gilead Sciences' Board Member Establishes Rule 10b5-1 Stock Trading Plan 13 May 2008 23:36 GMT
... Gilead Sciences' Board Member Establishes Rule 10b5-1 Stock Trading Plan FOSTER CITY, Calif., May 13, 2008 ...
- Who Owns the Rights on Tamiflu: Rumsfeld To Profit From Bird Flu Hoax 13 May 2008 04:51 GMT
... will make billions. While the drug is produced by Roche, it was developed by Gilead Sciences Inc.which owns the intellectual property rights. Gilead, which has maintained a low profile, has ...
- Bird Flu: A Corporate Bonanza for the Biotech Industry 13 May 2008 04:51 GMT
... article, the real point of interest is the company in California who developed Tamiflu, Gilead Sciences, listed on the NASDAQ as (GILD). As we also noted, US Secretary of Defense, ...
- Is Avian Flu another Pentagon Hoax? 13 May 2008 04:51 GMT
... to Roche. Tamiflu was developed and patented in 1996 by a California biotech firm, Gilead Sciences Inc. Gilead is a NASDAQ (GILD) listed stock company which prefers to maintain a ...
- Gilead Sciences names Chief Executive Martin as chairman 13 May 2008 04:37 GMT
... FOSTER CITY, Calif. (AP) - Gilead Sciences Inc. on Wednesday said that Chief Executive Officer John C. Martin was named chairman ...
- Gilead starts late stage test of hypertension drug 13 May 2008 04:37 GMT
... Gilead Sciences Inc. started a clinical test of a drug for pulmonary arterial hypertension. The Foster ...
- Gilead names new president, makes CEO its chairman, too 13 May 2008 04:37 GMT
... Gilead Sciences Inc. shuffled its upper ranks, making CEO John Martin chairman of its board of ...
- Closing Glance: Biotechnology stocks climb 13 May 2008 04:37 GMT
... rising dollar and falling oil prices. Here's how several key biotechnology stocks performed Monday: Gilead Sciences Inc., up 84 cents to $54.48. Amgen Inc., up 90 cents, or 2.1 percent, ...
- The Fortune Cookie Says ... 13 May 2008 04:37 GMT
... focus on what you know. If you just don't understand how biotech companies like Gilead Sciences (Nasdaq: GILD), Progenics Pharmaceuticals (Nasdaq: PGNX), and ImClone (Nasdaq: IMCL) make money, you won't ...
- Gilead Sciences EVP exercises options for 150,000 shares 13 May 2008 04:37 GMT
... NEW YORK (AP) - An executive vice president of biopharmaceutical company Gilead Sciences Inc. exercised options for 150,000 shares of and sold 180,000 shares of common stock, ...
- Gilead Appoints John C. Martin as Chairman of Board of... 13 May 2008 04:37 GMT
... CFO in the United States by Institutional Investor magazine in 2006, 2007 and 2008. Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of ...
- Gilead Sciences to Present at the Bank of America 2008... 13 May 2008 04:37 GMT
... ...
- Gilead Initiates Letairis(R) (ambrisentan) Phase IV Program 13 May 2008 04:37 GMT
... defects, cirrhosis of the liver and HIV infection. PAH afflicts approximately 200,000 patients worldwide. Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of ...
1 - 25 of 60 next >
News by PR Newswire
|
